Dementia drug use under scrutiny: are doctors prescribing correctly?
NCT ID NCT07313137
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at medical records of 683 older adults with dementia to see if their use of antiplatelet drugs (like aspirin) matched official guidelines. Researchers found that prescribing patterns varied across different types of dementia. The goal was to understand real-world practices and improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- antiplatelet therapy
- What this could lead to
- If successful, this could help doctors prescribe antiplatelet drugs more appropriately for people with dementia.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove whether antiplatelet therapy helps or harms dementia patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Could sharing lived experiences ease the burden of dementia care?
- A new tool aims to shield dementia patients from neglect
- Brain scans could unlock the hidden timeline of Alzheimer's